Suppr超能文献

钙通道阻滞剂与非神经元苯二氮䓬结合位点的相互作用。

Interaction of calcium channel blockers with non-neuronal benzodiazepine binding sites.

作者信息

Cantor E H, Kenessey A, Semenuk G, Spector S

出版信息

Proc Natl Acad Sci U S A. 1984 Mar;81(5):1549-52. doi: 10.1073/pnas.81.5.1549.

Abstract

The ability of calcium channel blockers to displace the binding of benzodiazepine ligands was investigated in rat heart, kidney, and brain. The dihydropyridine calcium channel blockers nifedipine and nitrendipine displaced the binding of the non-neuronal-site ligand [3H]Ro5-4864, but not that of the neuronal-site ligands [3H]flurazepam or [3H]clonazepam. The inhibition was competitive, with Ki values in the micromolar range. Other calcium channel blockers--i.e., verapamil and diltiazem--were inactive at both sites. Thus, non-neuronal benzodiazepines bind to a class of sites that also binds dihydropyridines. This implies a role for benzodiazepines in the mediation of calcium-dependent phenomena.

摘要

研究了钙通道阻滞剂在大鼠心脏、肾脏和大脑中取代苯二氮䓬配体结合的能力。二氢吡啶类钙通道阻滞剂硝苯地平和尼群地平能取代非神经元位点配体[3H]Ro5 - 4864的结合,但不能取代神经元位点配体[3H]氟西泮或[3H]氯硝西泮的结合。这种抑制是竞争性的,Ki值在微摩尔范围内。其他钙通道阻滞剂,即维拉帕米和地尔硫䓬,在这两个位点均无活性。因此,非神经元苯二氮䓬类药物与一类也能结合二氢吡啶的位点结合。这意味着苯二氮䓬类药物在钙依赖性现象的介导中发挥作用。

相似文献

引用本文的文献

6
Molecular biology of inhibitory amino acid receptors.抑制性氨基酸受体的分子生物学
Mol Neurobiol. 1987 Spring-Summer;1(1-2):155-89. doi: 10.1007/BF02935267.

本文引用的文献

2
Specific calcium antagonist binding sites in brain.大脑中的特异性钙拮抗剂结合位点。
Life Sci. 1982 Oct 11;31(15):1575-85. doi: 10.1016/0024-3205(82)90049-2.
6
Properties of two benzodiazepine binding sites in spinal cord.脊髓中两种苯二氮䓬结合位点的特性
Neuropharmacology. 1983 Jan;22(1):115-8. doi: 10.1016/0028-3908(83)90269-1.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验